Market Overview

Bank Of America Moves GNC And Vitamin Shoppe On Rating Changes

Share:

Bank of America expanded its coverage of the healthcare industry with ratings on GNC (NYSE: GNC) and Vitamin Shoppe (NYSE: VSI).

GNC: Buy from Neutral, $50 Price Objective from $47

Among catalysts for the upgrade is a record low amount of short interest. Aanalyst Curtis Nagle believes this may be the end of negative sentiment.

Nagle also wrote about the company’s new IT system, saying, “We believe that the adoption of Dunnhumby’s CRM and pricing platform will significantly increase the effectiveness of GNC’s loyalty program and pricing dynamics. In our opinion, the market does not appreciate the potential for Dunnhumby to sustainably drive comps for years to come.”

The $50 price target was derived with a 14 times forward earnings multiple. Shares of GNC are currently trading at just 12 times sales.

Related: Has Priceline Already Seen The Top?

Vitamin Shoppe: Upgrade to Neutral, $47 Price Target from $39

Nagle still believes Vitamin Shoppe’s multiples do not warrant a purchase of the stock. “We believe a Buy rating is not warranted because of lower store productivity and shares already trading at a healthy premium to the hardlines group and GNC. Cash is building, but we now view buybacks as unlikely given commentary that VSI is evaluating manufacturing opportunities.”

The $47 price target on Vitamin Shoppe implies a 17 times forward EPS multiple; the previous price target used a 15 times multiple.

Latest Ratings for GNC

DateFirmActionFromTo
Jun 2019Initiates Coverage OnHold
Oct 2018Initiates Coverage OnBuy
May 2018ReinstatesEqual-WeightEqual-Weight

View More Analyst Ratings for GNC
View the Latest Analyst Ratings

Posted-In: Bank of America Curtis NagleAnalyst Color Upgrades Price Target Analyst Ratings

 

Related Articles (VSI + GNC)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
MJP MorganMaintains13.0
IPARDA DavidsonMaintains76.0
BSBRUBSUpgrades
TGTMorgan StanleyMaintains130.0
VCMorgan StanleyMaintains52.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Walgreens Releases May Sales

UPDATE: TransCanada Announces Will Proceed with C$1.9B Merrick Mainline Pipeline, Expecting Delivery Volumes to Ramp Up 2020-2022 to 1.9bcf/Day